Le Lézard
Classified in: Health
Subjects: NPT, WOM, AVO, DEI

National Institute for Reproductive Health (NIRH) Announces Honorees for 2022 Champions of Choice Awards Luncheon


Award-winning Actress/Comedian/Director/Producer Amy Schumer, Emmy-nominated Actress/Comedian Cecily Strong, President/CEO of Desert Star Family Planning Dr. DeShawn Taylor to be Honored for their Continuous Support of Reproductive Freedom

NEW YORK, April 6, 2022 /PRNewswire/ -- The National Institute for Reproductive Health (NIRH) and NIRH Action Fund is proud to announce the honorees for its annual Champions of Choice awards luncheon to be held Wednesday, April 27, 2022, from 12:00pm ? 2:00pm ET at Ziegfeld Ballroom (141 W 54th St.) in New York City.  Known as the New York's premiere reproductive rights events and attended by more than 500 prominent leaders in philanthropy, business, media, and politics, this year's event will recognize three individuals for their ongoing commitment and use of influence to advocate for reproductive health, rights, and justice.  The program will be emceed by media personality Aisha C. Mills, a member of the NIRH Action Fund Board of Directors.

The 2022 honorees include actress/comedian/director/producer Amy Schumer, Emmy-nominated actress/comedian Cecily Strong and President/CEO of Desert Star Family Planning Dr. DeShawn Taylor

Champions of Choice is co-chaired by board members Dr. Cailin Fiss, Dr. Elizabeth Comen and filmmaker Dawn PorterHonorary Chairs include Amy Brenneman (actress, writer, producer, activist), Kate Walsh (actress, entrepreneur, activist), Alysia Reiner (actress, producer), Merrin Dungey (actress, producer), Bonnie Fuller (CEO/editor of Hollywood Life), Lysa Heslov (director/producer), Lara Marcon (philanthropist), Nancy Silverman (philanthropist) and Lola C. West (financial advisor, change-maker).

"In 2022, reproductive freedom is being threatened like never before, with the Supreme Court set to overturn Roe v. Wade and multiple states having already banned abortion," says Andrea Miller, President of the National Institute for Reproductive Health and NIRH Action Fund.  "None of us can fight this battle alone ? that's why we're thrilled to come together with abortion providers, activists, advocates, philanthropists, elected officials, and cultural leaders willing to use their platforms to destigmatize abortion care and speak truth to power."

The National Institute for Reproductive Health (NIRH) and the National Institute for Reproductive Health Action Fund (NIRH Action Fund) are advocacy groups that fight for just and equitable access to reproductive health care and build political power for reproductive freedom. NIRH and its Action Fund launch campaigns, change policy, and elect candidates, all by working hand-in-hand with reproductive health, rights, and justice organizations in states and cities across the country. What makes NIRH unique is their approach of going on the offense to pass laws to ensure people get the care they need, while putting protections in place to counter efforts to further erode access to abortion, contraception, and maternal health care. NIRH's approach to advocacy, policy, and politics strives to center the people who are most impacted by barriers to care, historically underserved, and often under-represented -- Black women and Black communities, Indigenous and other communities of color, low-income people, young people, and immigrants.

In past years, NIRH has honored important policymakers including Representative Ayanna Pressley, United States Senator Kirsten Gillibrand, NYS Senator & Majority leader Andrea Stewart Cousins, NYS Assembly member & Speaker Carl E. Hastie, and former Mayor Michael R. Bloomberg; those in popular culture and the media who have made it a priority to speak out on these issues, including Joanna Coles, Whoopi Goldberg, Kate Walsh, and Lizz Winstead; and courageous independent abortion providers such as Kwajelyn Jackson and Amy Hagstrom Miller

Tickets for the Champions of Choice luncheon are $500 per person and can be purchased at www.nirhealth.org.  Sponsorship opportunities are still available and can be directed to Shannon Carey at [email protected].  

About NIRH and NIRH Action Fund
The National Institute for Reproductive Health (NIRH) and the National Institute for Reproductive Health Action Fund (NIRH Action Fund) are advocacy groups that fight for just and equitable access to reproductive health care and build political power for reproductive freedom. We launch campaigns, change policy, and elect candidates, all by working hand-in-hand with reproductive health, rights, and justice organizations in states and cities across the country. We work in the communities the need is great and we can make a difference, so the fabric of reproductive freedom is harder to tear apart.  www.nirhealth.org.  

Contact:
Daphne Ortiz
Statement PR
323.864.9890
[email protected]

SOURCE National Institute for Reproductive Health


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: